Oral minoxidil is a good option for individuals with androgenic alopecia who experience side effects from topical minoxidil or who are not seeing the results they hoped for. You can get an oral ...

Please provide your email address to receive an email when new articles are posted on . Effective Jan. 1, 2025, CMS will begin including phosphate-binders in the end-stage renal disease prospective ...

Eli Lilly and Company's orforglipron shows strong efficacy and manufacturing advantages over Novo Nordisk's oral semaglutide, supporting future growth in the obesity and diabetes market.